Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Alnylam pays Inceptive $30M to transform siRNA design
Alnylam has partnered with the person who helped put the “T” in ChatGPT, paying $30 million to work with Inceptive Nucleics on AI-enabled drug design.
Nick Paul Taylor
Jun 4, 2026 4:13am
Regeneron pays $37M, adds $2B in biobucks to expand CytomX pact
Jun 3, 2026 9:48am
PATH-Solution
Brought to you by
Alfresa Holdings Corporation
Ascidian, Lilly ink RNA exon editing pact worth up to $1.9B
Jun 3, 2026 7:00am
Carl Sailer on AI, market trends, and strategic planning in biotech
Brought to you by
Syneos Health
Anti-aging biotech NewLimit nabs $435M to rejuvenate old cells
Jun 2, 2026 1:00pm